Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Giannoukakis

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Gene Therapy|March 26, 2008
Type 1 diabetes: MHC tailored for diabetes cell therapyM Trucco, N Giannoukakis
Diabetes, Nutrition & Metabolism|August 14, 2002
Therapeutic strategies for Type 1 and Type 2 diabetes mellitusN Giannoukakis, M Pietropaolo, M Trucco
Gene Therapy|September 22, 1999
Gene therapy in transplantationN Giannoukakis, A Thomson, P Robbins
Developmental Genetics|January 1, 1995
Imprinting of IGF2, insulin-dependent diabetes, immune function, and apoptosis: a hypothesisC Polychronakos, N Giannoukakis, C L Deal
Gene Therapy|May 7, 2003
Gene- and cell-based therapeutics for type I diabetes mellitusR Bottino, P Lemarchand, M Trucco, et al.
Diabetologia|June 1, 1995
Parental imprinting effect at the INS-IGF2 diabetes susceptibility locusC Polychronakos, A Kukuvitis, N Giannoukakis, et al.
The Journal of Biological Chemistry|June 11, 1998
The INS 5' variable number of tandem repeats is associated with IGF2 expression in humansJ Paquette, N Giannoukakis, C Polychronakos, et al.
The Journal of Biological Chemistry|September 1, 2000
Protection of human islets from the effects of interleukin-1beta by adenoviral gene transfer of an Ikappa B repressorN Giannoukakis, W A Rudert, M Trucco, et al.
Biochemical and Biophysical Research Communications|March 27, 1996
Polymorphic functional imprinting of the human IGF2 gene among individuals, in blood cells, is associated with H19 expressionN Giannoukakis, C Deal, J Paquette, et al.
Diabetes|October 27, 1999
Targeting autoimmune diabetes with gene therapyN Giannoukakis, W A Rudert, P D Robbins, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Gene Therapy|March 26, 2008
Type 1 diabetes: MHC tailored for diabetes cell therapyM Trucco, N Giannoukakis
Diabetes, Nutrition & Metabolism|August 14, 2002
Therapeutic strategies for Type 1 and Type 2 diabetes mellitusN Giannoukakis, M Pietropaolo, M Trucco
Gene Therapy|September 22, 1999
Gene therapy in transplantationN Giannoukakis, A Thomson, P Robbins
Developmental Genetics|January 1, 1995
Imprinting of IGF2, insulin-dependent diabetes, immune function, and apoptosis: a hypothesisC Polychronakos, N Giannoukakis, C L Deal
Gene Therapy|May 7, 2003
Gene- and cell-based therapeutics for type I diabetes mellitusR Bottino, P Lemarchand, M Trucco, et al.
Diabetologia|June 1, 1995
Parental imprinting effect at the INS-IGF2 diabetes susceptibility locusC Polychronakos, A Kukuvitis, N Giannoukakis, et al.
The Journal of Biological Chemistry|June 11, 1998
The INS 5' variable number of tandem repeats is associated with IGF2 expression in humansJ Paquette, N Giannoukakis, C Polychronakos, et al.
The Journal of Biological Chemistry|September 1, 2000
Protection of human islets from the effects of interleukin-1beta by adenoviral gene transfer of an Ikappa B repressorN Giannoukakis, W A Rudert, M Trucco, et al.
Biochemical and Biophysical Research Communications|March 27, 1996
Polymorphic functional imprinting of the human IGF2 gene among individuals, in blood cells, is associated with H19 expressionN Giannoukakis, C Deal, J Paquette, et al.
Diabetes|October 27, 1999
Targeting autoimmune diabetes with gene therapyN Giannoukakis, W A Rudert, P D Robbins, et al.
Pageof 2